Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurens A Van Kleef

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Cancers|October 27, 2022
Is Fasting Good When One Is at Risk of Liver Cancer?Iulia Minciuna, Laurens A van Kleef, Horia Stefanescu, et al.
Hepatology (Baltimore, Md.)|July 1, 2022
Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortalityLaurens A van Kleef, Robert J de Knegt, Willem Pieter Brouwer
The American Journal of Gastroenterology|December 14, 2021
Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam StudyLaurens A van Kleef, Amy Hofman, Trudy Voortman, et al.
Journal of Clinical and Experimental Hepatology|March 17, 2025
Diagnostic Accuracy of the LiverRisk Score to Detect Increased Liver Stiffness Among a United States General Population and SubgroupsLaurens A van Kleef, Jesse Pustjens, Harry L A Janssen, et al.
Drug Design, Development and Therapy|March 23, 2026
Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH)Laurens A Van Kleef, Maurice Michel, Naim Alkhouri, et al.
World Journal of Gastroenterology|September 30, 2025
Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populationsJesse Pustjens, Willem P Brouwer, Ibrahim Ayada, et al.
Hepatology Communications|April 7, 2023
The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US populationLaurens A van Kleef, Robert J de Knegt, Ibrahim Ayada, et al.
Plos One|September 8, 2023
Fatty Liver Index and mortality after myocardial infarction: A prospective analysis in the Alpha Omega CohortLuc Heerkens, Laurens A van Kleef, Robert J de Knegt, et al.
Journal of Clinical and Experimental Hepatology|May 30, 2023
Spleen Stiffness Measurement Across the Spectrum of Liver Disease Patients in Real-World PracticeMarten A Lantinga, Laurens A van Kleef, Caroline M den Hoed, et al.
Neurology|May 26, 2022
Association of Nonalcoholic Fatty Liver Disease and Fibrosis With Incident Dementia and Cognition: The Rotterdam StudyTian Xiao, Laurens A van Kleef, M Kamran Ikram, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Cancers|October 27, 2022
Is Fasting Good When One Is at Risk of Liver Cancer?Iulia Minciuna, Laurens A van Kleef, Horia Stefanescu, et al.
Hepatology (Baltimore, Md.)|July 1, 2022
Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortalityLaurens A van Kleef, Robert J de Knegt, Willem Pieter Brouwer
The American Journal of Gastroenterology|December 14, 2021
Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam StudyLaurens A van Kleef, Amy Hofman, Trudy Voortman, et al.
Journal of Clinical and Experimental Hepatology|March 17, 2025
Diagnostic Accuracy of the LiverRisk Score to Detect Increased Liver Stiffness Among a United States General Population and SubgroupsLaurens A van Kleef, Jesse Pustjens, Harry L A Janssen, et al.
Drug Design, Development and Therapy|March 23, 2026
Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH)Laurens A Van Kleef, Maurice Michel, Naim Alkhouri, et al.
World Journal of Gastroenterology|September 30, 2025
Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populationsJesse Pustjens, Willem P Brouwer, Ibrahim Ayada, et al.
Hepatology Communications|April 7, 2023
The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US populationLaurens A van Kleef, Robert J de Knegt, Ibrahim Ayada, et al.
Plos One|September 8, 2023
Fatty Liver Index and mortality after myocardial infarction: A prospective analysis in the Alpha Omega CohortLuc Heerkens, Laurens A van Kleef, Robert J de Knegt, et al.
Journal of Clinical and Experimental Hepatology|May 30, 2023
Spleen Stiffness Measurement Across the Spectrum of Liver Disease Patients in Real-World PracticeMarten A Lantinga, Laurens A van Kleef, Caroline M den Hoed, et al.
Neurology|May 26, 2022
Association of Nonalcoholic Fatty Liver Disease and Fibrosis With Incident Dementia and Cognition: The Rotterdam StudyTian Xiao, Laurens A van Kleef, M Kamran Ikram, et al.
Pageof 4